SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+82.83%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$104M
AUM Growth
–
Cap. Flow
+$104M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
53.66%
Holding
49
New
49
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Grifois
GRFS
|
$10.5M |
| 2 |
ESSA Pharma
EPIX
|
$8.99M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
$6.91M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$5.73M |
| 5 |
AGN
Allergan plc
AGN
|
$5.45M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 96.31% |
| 2 | Real Estate | 0.65% |
| 3 | Communication Services | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Grifois
GRFS
$6.78B
| $10.5M | 10.17% | +452,900 | New | +$10.5M |
|
|
2
ESSA Pharma
EPIX
$11.4M
| $8.99M | 8.67% | +1,634,369 | New | +$8.99M |
|
|
WMGI
3
DELISTED
Wright Medical Group Inc
WMGI
| $6.91M | 6.66% | +226,700 | New | +$6.91M |
|
|
ISEE
4
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.73M | 5.53% | +668,371 | New | +$5.73M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $5.45M | 5.25% | +28,500 | New | +$5.45M |
|
6
Adverum Biotechnologies
ADVM
$64.6M
| $3.95M | 3.81% | +342,800 | New | +$3.95M |
|
7
DexCom
DXCM
$29.5B
| $3.85M | 3.71% | +17,600 | New | +$3.85M |
|
8
Spyre Therapeutics
SYRE
$996M
| $3.5M | 3.38% | +458,165 | New | +$3.5M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.39M | 3.26% | +31,300 | New | +$3.39M |
|
|
MSON
10
DELISTED
Misonix Inc
MSON
| $3.32M | 3.21% | +178,596 | New | +$3.32M |
|
11
iRadimed
IRMD
$921M
| $3.29M | 3.17% | +140,752 | New | +$3.29M |
|
12
Vericel Corp
VCEL
$1.83B
| $3.2M | 3.08% | +183,680 | New | +$3.2M |
|
|
EIGR
13
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.06M | 2.95% | +205,407 | New | +$3.06M |
|
14
Establishment Labs
ESTA
$1.2B
| $2.59M | 2.5% | +93,560 | New | +$2.59M |
|
|
DERM
15
DELISTED
Dermira, Inc.
DERM
| $2.5M | 2.41% | +164,600 | New | +$2.5M |
|
16
Axogen
AXGN
$743M
| $2.28M | 2.2% | +127,450 | New | +$2.28M |
|
17
Biogen
BIIB
$19.4B
| $2.23M | 2.15% | +7,500 | New | +$2.23M |
|
18
Humana
HUM
$36.5B
| $2.13M | 2.05% | +5,800 | New | +$2.13M |
|
19
Xenon Pharmaceuticals
XENE
$2.98B
| $2.12M | 2.04% | +161,600 | New | +$2.12M |
|
|
BPMC
20
DELISTED
Blueprint Medicines
BPMC
| $2.11M | 2.04% | +26,400 | New | +$2.11M |
|
|
CNST
21
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1.98M | 1.91% | +42,100 | New | +$1.98M |
|
22
Amicus Therapeutics
FOLD
$2.34B
| $1.84M | 1.77% | +188,800 | New | +$1.84M |
|
|
HARP
23
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.82M | 1.76% | +123,200 | New | +$1.82M |
|
|
KDMN
24
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.59M | 1.53% | +350,300 | New | +$1.59M |
|
25
CRISPR Therapeutics
CRSP
$4.71B
| $1.36M | 1.31% | +22,300 | New | +$1.36M |
|